Senexin B
Product Specifications
Background
Senexin B is a potent inhibitor of cyclin-dependent kinases 8 and 19.1 It suppressed tumor growth and augmented the effects of fulvestrant in ER-positive breast cancer xenografts. KD50s: CDK8 = 59 nM, CDK19 = 23 nM.2 Senexin B also showed synergistic effects with lapatinib and trastuzumab in a panel of HER2+ breast cancer cell lines. Senexin B and ALK5 inhibitor SB431542 afforded generation of pancreatic islet cells from pluripotent stem cells without any mutagenic effects.4 Combination treatment of Senexin B and Imatinib intensified apoptotic cell death in chronic myelogenous leukemia cells and prevented quiescence-mediated escape from apoptosis.5
Conjugation
Unconjugated
Buffer
Off-white solid
Storage Conditions
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6441561-01 0.1 mL
TRADD (Tumor Necrosis Factor Receptor 1 Associated Death Domain, Hs.89862, MGC11078) (MaxLight 490)
Sign In for Pricing
View Details MBS6441561-02 5x 0.1 mL
TRADD (Tumor Necrosis Factor Receptor 1 Associated Death Domain, Hs.89862, MGC11078) (MaxLight 490)
Sign In for Pricing
View Details 
LV650203 1.0 µg DNA
PCDHB10 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details ![Recombinant Bradyrhizobium sp. Phosphoenolpyruvate carboxykinase [ATP] (pckA), partial](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
MBS1078797 Inquire
Recombinant Bradyrhizobium sp. Phosphoenolpyruvate carboxykinase [ATP] (pckA), partial
Sign In for Pricing
View Details MBS6323047-01 0.2 mL
MUTED, ID (MUTED, Protein Muted homolog) (FITC)
Sign In for Pricing
View Details